Literature DB >> 11276612

Dysphagia among nursing home residents: an assessment and management protocol.

C Shanley1, G O'Loughlin.   

Abstract

The literature suggests that 40% to 60% of nursing home residents have some degree of dysphagia, i.e., difficulty in swallowing. Poorly managed, this can lead to aspiration pneumonia; choking; chronic malnutrition; decreased quality of life; and frustration for residents, family, and staff. This article reviews the nursing literature on dysphagia management and then describes a comprehensive protocol to assess and manage patients with swallowing problems in long term care.

Entities:  

Mesh:

Year:  2000        PMID: 11276612     DOI: 10.3928/0098-9134-20000801-09

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  4 in total

Review 1.  Nutritional assessment of residents in long-term care facilities (LTCFs): recommendations of the task force on nutrition and ageing of the IAGG European region and the IANA.

Authors:  A Salva; L Coll-Planas; S Bruce; L De Groot; S Andrieu; G Abellan; B Vellas; Sandrine Andrieu; Luisa Bartorelli; Ytshal N Berner; Stuart Bruce; Bruno Corman; Alex Domingo; Thomas P Egger; Lisette de Groot; Yves Guigoz; Ana Imedio; Mercè Planas; Concha Porras; Joan Carles Rovira; Antoni Salvà; José Antonio Serra; Bruno Vellas
Journal:  J Nutr Health Aging       Date:  2009-06       Impact factor: 4.075

2.  Evaluation of swallowing movement using ultrasonography.

Authors:  Takao Matsuo; Miwa Matsuyama; Ken Nakatani; Naoe Mori
Journal:  Radiol Phys Technol       Date:  2019-11-30

3.  Prevalence and risk factors for dysphagia: a USA community study.

Authors:  S Y Cho; R S Choung; Y A Saito; C D Schleck; A R Zinsmeister; G R Locke; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2014-11-06       Impact factor: 3.598

Review 4.  Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders.

Authors:  Fabio Baldi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.